Atlas Trials

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Clinical trial NCT04816916 · TERMINATED

Trial details

NCT number
NCT04816916
Sponsor
Axcella Health, Inc
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatic Encephalopathy
Start date
2021-06-29
Primary completion
2022-06-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.